Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals, Inc., is a global biotechnology company that aims to discover, develop, and commercialize medicines for people with serious diseases. In addition to its clinical development programs focused on cystic fibrosis, it has more than a dozen other ongoing research programs aimed at serious and life-threatening diseases. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.